A multisite randomized trial of portable sleep studies and positive airway pressure autotitration versus laboratory-based polysomnography for the diagnosis and treatment of obstructive sleep apnea: the HomePAP study
- PMID: 22654195
- PMCID: PMC3353048
- DOI: 10.5665/sleep.1870
A multisite randomized trial of portable sleep studies and positive airway pressure autotitration versus laboratory-based polysomnography for the diagnosis and treatment of obstructive sleep apnea: the HomePAP study
Abstract
Study objectives: To test the utility of an integrated clinical pathway for obstructive sleep apnea (OSA) diagnosis and continuous positive airway pressure (CPAP) treatment using portable monitoring devices.
Design: Randomized, open-label, parallel group, unblinded, multicenter clinical trial comparing home-based, unattended portable monitoring for diagnosis and autotitrating CPAP (autoPAP) compared with in-laboratory polysomnography (PSG) and CPAP titration.
Setting: Seven American Academy of Sleep Medicine (AASM) accredited sleep centers.
Participants: Consecutive new referrals, age 18 yr or older with high probability of moderate to severe OSA (apnea-hypopnea index [AHI] ≥ 15) identified by clinical algorithm and Epworth Sleepiness Scale (ESS) score ≥ 12.
Interventions: Home-based level 3 testing followed by 1 wk of autoPAP with a fixed pressure CPAP prescription based on the 90% pressure from autotitration of PAP therapy (autoPAP) device (HOME) compared with attended, in-laboratory studies (LAB).
Measurements: CPAP acceptance, time to treatment, adherence at 1 and 3 mo; changes in ESS, and functional outcomes.
Results: Of 373 participants, approximately one-half in each study arm remained eligible (AHI ≥ 15) to continue in the study. At 3 mo, PAP usage (nightly time at pressure) was 1 hr greater: 4.7 ± 2.1 hr (HOME) compared with 3.7 ± 2.4 hr (LAB). Adherence (percentage of night used ≥ 4 hr) was 12.6% higher: 62.8 ± 29.2% compared with 49.4 ± 36.1% in the HOME versus LAB. Acceptance of PAP therapy, titration pressures, effective titrations, time to treatment, and ESS score change did not differ between arms.
Conclusions: A home-based strategy for diagnosis and treatment compared with in-laboratory PSG was not inferior in terms of acceptance, adherence, time to treatment, and functional improvements.
Trial registration: http://www.ClinicalTrials.gov; Identifier: NCT: 00642486.
Trial registration: ClinicalTrials.gov NCT00642486.
Keywords: OSA; autotitration; diagnosis; portable monitoring; randomized clinical trial.
Figures


Comment in
-
"The times they are a changin:" home diagnosis of sleep apnea has arrived.Sleep. 2012 Jun 1;35(6):735-6. doi: 10.5665/sleep.1848. Sleep. 2012. PMID: 22654184 Free PMC article. No abstract available.
References
-
- Esparis B. Accreditation Statistics, Report to the Board of Directors, American Academy of Sleep Medicine (personal communication to JA Barrett) 2011
-
- AASM Special Update. Darien, Il: American Academy of Sleep Medicine; 2011. CMS Revises Sleep Medicine CPT Codes.
-
- Rosen C, Auckley D, Benca R, et al. A multi-site randomized rrial of portable monitoring and positive airway pressure autotitration versus laboratory-based polysomnography for thediagnosis and management of obstructive sleep apnea: HomePAP study. Sleep. 2010;33(Abstract supplement):A173. - PMC - PubMed
-
- Flemons WW, Whitelaw WA, Brant R, Remmers JE. Likelihood ratios for a sleep apnea clinical prediction rule. Am J Respir Crit Care Med. 1994;150(5 Pt 1):1279–85. - PubMed
-
- Flemons WW. Clinical practice:obstructive sleep apnea. N Engl J Med. 2002;347:498–504. - PubMed
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous